Dna X (SONM) Revenue (2018 - 2025)

Dna X has reported Revenue for 8 years, with the latest figure at $16.2 million in Q3 2025.

• For the quarter ending Q3 2025, Revenue rose 7.94% year-over-year to $16.2 million; the trailing twelve-month figure through Sep 2025 stood at $59.1 million (up 4.17% YoY), and the FY2024 full-year result was $58.3 million, down 37.74% from the prior year.
• Revenue for Q3 2025 stood at $16.2 million, up from $11.2 million in the prior quarter.
• The five-year high for Revenue was $27.6 million in Q3 2023, with the low at $11.2 million in Q2 2025.
• Historically, Revenue has averaged $16.9 million across 5 years, with a median of $15.0 million in 2024.
• Annual changes were most pronounced in 2023 — Revenue jumped 124.47% — and 2024, when it sank 57.09%.
• Dna X's Revenue stood at $15.9 million in 2021, then surged by 51.39% to $24.1 million in 2022, then plunged by 44.32% to $13.4 million in 2023, then gained by 11.57% to $15.0 million in 2024, then rose by 8.21% to $16.2 million in 2025.
• The last three Revenue figures came in at $16.2 million (Q3 2025), $11.2 million (Q2 2025), and $16.7 million (Q1 2025), per Business Quant data.